Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 blockade therapy has been trialed in a broad range of malignancies and achieved clinical success. Despite the potentially cure-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jin-Yu, Zhang, Dengke, Wu, Songquan, Xu, Min, Zhou, Xiao, Lu, Xiao-Jie, Ji, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450549/
https://www.ncbi.nlm.nih.gov/pubmed/32864132
http://dx.doi.org/10.1186/s40364-020-00212-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450549/
https://www.ncbi.nlm.nih.gov/pubmed/32864132
http://dx.doi.org/10.1186/s40364-020-00212-5

Ejemplares similares